User contributions

Jump to navigation Jump to search
Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽

(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)

  • 06:50, 25 October 2016 diff hist -368 m Hepatocellular carcinomaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:48, 25 October 2016 diff hist -3,496 m Head and neck cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:48, 25 October 2016 diff hist -184 m Chronic myelomonocytic leukemiaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:47, 25 October 2016 diff hist -92 m Editing test pageText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:46, 25 October 2016 diff hist -92 m Myelodysplastic syndromeText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:46, 25 October 2016 diff hist -1,288 m Ovarian cancerText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:46, 25 October 2016 diff hist -184 m CNS lymphomaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:46, 25 October 2016 diff hist -92 m Peripheral T-cell lymphomaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:46, 25 October 2016 diff hist -2,208 m Acute promyelocytic leukemiaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:46, 25 October 2016 diff hist -92 m Paroxysmal nocturnal hemoglobinuriaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:44, 25 October 2016 diff hist -368 m B-cell acute lymphoblastic leukemiaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:44, 25 October 2016 diff hist -552 m Malignant pleural mesotheliomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:44, 25 October 2016 diff hist -1,656 m OsteosarcomaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:43, 25 October 2016 diff hist -184 m Erdheim-Chester diseaseText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:43, 25 October 2016 diff hist -552 m Thyroid cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:42, 25 October 2016 diff hist -92 m Large granular lymphocytic leukemiaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:41, 25 October 2016 diff hist -368 m Urothelial carcinomaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:41, 25 October 2016 diff hist -828 m Acute promyelocytic leukemiaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 06:40, 25 October 2016 diff hist -2,484 m Urothelial carcinomaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:37, 25 October 2016 diff hist -276 m Head and neck cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:37, 25 October 2016 diff hist -92 m Levels of EvidenceText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:37, 25 October 2016 diff hist -92 m Pancreatic cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:35, 25 October 2016 diff hist -184 m Pancreatic cancerText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:35, 25 October 2016 diff hist -276 m Immune thrombocytopeniaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:34, 25 October 2016 diff hist -92 m Transplant conditioning regimensText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:34, 25 October 2016 diff hist -92 m ThymomaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:34, 25 October 2016 diff hist -92 m Mediastinal gray-zone lymphomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:33, 25 October 2016 diff hist -1,104 m Chronic myeloid leukemiaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:32, 25 October 2016 diff hist -1,748 m Diffuse large B-cell lymphoma - historicalText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:32, 25 October 2016 diff hist -2,024 m Light-chain (AL) amyloidosisText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:30, 25 October 2016 diff hist -92 m Diffuse large B-cell lymphoma - historicalText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 06:29, 25 October 2016 diff hist -1,656 m Small cell lung cancerText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:28, 25 October 2016 diff hist -276 m Burkitt lymphomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 06:28, 25 October 2016 diff hist -1,840 m Waldenström macroglobulinemiaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:28, 25 October 2016 diff hist -368 m Systemic mastocytosisText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:28, 25 October 2016 diff hist -184 m Chronic myeloid leukemiaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 06:27, 25 October 2016 diff hist -184 m Systemic mastocytosisText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:27, 25 October 2016 diff hist -184 m ThymomaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:26, 25 October 2016 diff hist -184 m Hepatocellular carcinomaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:26, 25 October 2016 diff hist -460 m Anaplastic gliomaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:25, 25 October 2016 diff hist -276 m Gemtuzumab ozogamicin (Mylotarg)Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:25, 25 October 2016 diff hist -276 m Multiple myeloma - historicalText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:25, 25 October 2016 diff hist -92 m Waldenström macroglobulinemiaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:24, 25 October 2016 diff hist -92 m Marginal zone lymphomaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:24, 25 October 2016 diff hist -368 m Carcinoma of unknown primaryText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:24, 25 October 2016 diff hist -828 m Urothelial carcinomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:23, 25 October 2016 diff hist -184 m MyelofibrosisText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:23, 25 October 2016 diff hist -92 m Breast cancerText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 06:22, 25 October 2016 diff hist -368 m Small cell lung cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:22, 25 October 2016 diff hist -276 m Polycythemia veraText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"

(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)